CARROLLTON CITY HALL INFOBusiness Directories,Company Directories

Company Name: Corporate Name:	CARROLLTON CITY HALL INFO
Company Title:	City of Carrollton, Texas : Home
Company Description:
Keywords to Search:
Company Address:	1945 E Jackson Rd,CARROLLTON,TX,USA
ZIP Code: Postal Code:	75006-1737
Telephone Number:	9724663252 (+1-972-466-3252)
Fax Number:	9724663000 (+1-972-466-3000)
Website:	www. cityofcarrollton. com
Email:
USA SIC Code(Standard Industrial Classification Code):	911104
USA SIC Description:	City Government-Executive Offices
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
HAROLD L PUTNEY INC
HANURI KOREAN CHURCH
CENTEX HOMES-DFW

Next company profile:
ADS COMPUTER
ARGENT MORTGAGE COMPANY
TABANI GROUP INC

Company News:

Lung Cancer - Medscape
Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer Read the latest
Small Cell Lung Cancer in 2024: Treatment Advances - Medscape
This is Mark Kris, going over developments in small cell lung cancer in 2024 that have advanced therapy in the field I think the most dramatic one is the long overdue emergence of checkpoint
Two Lung Cancer Drugs Recommended by EMA - Medscape
Is Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer? Small Cell Lung Cancer in 2024: Treatment Advances 3090D553-9492-4563-8681-AD288FA52ACE
Advanced Non-Small Cell Lung Cancer Updates From ASCO 2024 - Medscape
Practice-changing studies in advanced non-small cell lung cancer presented at ASCO 2024 are reviewed by Dr Ticiana Leal, including the phase 3 LAURA and PALOMA-3 studies and a 5-year update of CROWN
Why a New Inhalable Lung Cancer Treatment Is So Promising - Medscape
Cheng, who has been developing exosome and stem cell therapies for more than 15 years, and his lab team focused on lung cancer because the disease, often detected in later stages, "has a huge
Potential Drivers of LCINS - Medscape
During a plenary session at the 2024 World Congress on Lung Cancer, experts addressed the known and suspected causes of LCINS, including fallout from climate change, vaping, cannabis use, and
Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung . . .
Dr Narjust Florez explores the transformative shifts in the treatment landscape for early-stage non–small cell lung cancer over the years, particularly emphasizing the significant changes
Zenocutuzumab Effective Against NRG1 Fusion Cancers - Medscape
The bispecific antibody shows particularly promising results in non–small cell lung cancer (NSCLC) and pancreatic cancer patients, with responses lasting a median of 11 1 months
Evaluation and Management of Small Pulmonary Nodules - Page 3 - Medscape
Lung nodules in the right lung and in the upper lobes have a higher probability for malignancy [ 17 , 45 ] Some studies indicate that 70% of all lung cancers are located in the upper lobes
Early Detection and Screening of Lung Cancer - Page 2 - Medscape
Expert Rev Mol Diagn 2010;10(6):799-815 Screening and early detection of lung cancer brings up many challenges One is the 'lead time bias', where the screening test has no real effect on the